Name: Pharmaceutical 1.084g/Cm3 CAS 83435-58-9 Boc-D-Prolinol
Brand: Zhihua
SKU: Handmade

Pharmaceutical 1.084g/Cm3 CAS 83435-58-9 Boc-D-Prolinol

Product Details:

Place of Origin:	Made in China
Brand Name:	Zhihua
Model Number:	Handmade

Payment & Shipping Terms:

Minimum Order Quantity:	1 Piece
Price:	To be negotiated
Packaging Details:	1KGS/Carton
Delivery Time:	3-20Days
Payment Terms:	L/C, D/A, D/P, T/T, Western Union, MoneyGram
Supply Ability:	1000Ton/Month

Contact Now

Detailed Product Description

Product Name:	Boc-D-prolinol	CAS:	83435-58-9
Molecular Formula:	C10H19NO3	Molecular Weight:	201.26
Application(s):	Peptide Synthesis: Suitable	Boiling Point:	289.5±13.0 °C(Predicted)
Density :	1.084±0.06 G/cm3(Predicted)	Form:	Crystalline Powder
High Light:	Pharmaceutical CAS 83435-58-9 , 1.084g/cm3 CAS 83435-58-9 , Pharmaceutical Boc-D-Prolinol

CAS 83435-58-9 Boc-D-Prolinol

Melting point: :60-64 °C(lit.)
alpha :49 º (589nm, =1.3, CHCl3)
Boiling point: :289.5±13.0 °C(Predicted)
Density :1.084±0.06 g/cm3(Predicted)
refractive index :54 ° (C=5, MeOH)
storage temp. :Store at 0°C
form :Crystalline Powder
pka :14.77±0.10(Predicted)
color :White to light beige
optical activity :[α]23/D +50°, c = 1.3 in chloroform
Water Solubility :insoluble

Name	High quality Boc-D-prolinol cas 83435-58-9 with best price
Other name	(R)-(+)-1-(tert-Butoxycarbonyl)-2-pyrrolidinemethanol;N-Boc-D-prolinol;N-(tert-Butoxycarbonyl)-D-prolinol;N-t-BOC-D-Prolinol;
CAS	83435-58-9
Applications	Organic intermediate; Intermediates of pyrotinib
Appearance	White Powder

Product name	Boc-D-prolinol
CAS	83435-58-9
Synonyms	BOC-D-PRO-OL;BOC-D-PROLINOL;BOC-(R)-2-(HYDROXYMETHYL) PYRROLIDINE;N-TERT-BUTOXYCARBONYL-D-PROLINOL;N-T-BUTOXYCARBONYL-D-PROLINOL;N-T-BOC-D-PROLINOL;N-BOC-D-PROLINOL;N-ALPHA-T-BOC-D-PROLINOLChemicalBook
Molecular formula	C10H19NO3
Molecular weight	201.26
Purity	99%
Appearance	White powder
EINECS number	626-169-6

Boc-D-prolinol CAS 83435-58-9 is white powder. It is an organic intermediate compound. It is an important intermediate of pyrotinib. Pyrotinib is a novel irreversible epidermal growth factor receptor/HER2 dual tyrosine kinase inhibitor.

Pyrotinib is an irreversible dual pan-ErbB receptor tyrosine kinase inhibitor developed for the treatment of HER2-positive advanced solid tumours. Based on positive results in a phase II trial, the drug recently received conditional approval in China for use in combination with capecitabine for the treatment of HER2-positive, advanced or metastatic breast cancer in patients previously treated with anthracycline or taxane chemotherapy.

Boc-D-prolinol CAS 83435-58-9 could be supplied in commercial size with competitive price.

Tag:

Contact Person: Xiaojun Ji

Tel: 086-13774313779

Send your inquiry directly to us